A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells.
about
A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A novel agent SL-401 induces a ...... is and cancer stem-like cells.
@en
A novel agent SL-401 induces a ...... is and cancer stem-like cells.
@nl
type
label
A novel agent SL-401 induces a ...... is and cancer stem-like cells.
@en
A novel agent SL-401 induces a ...... is and cancer stem-like cells.
@nl
prefLabel
A novel agent SL-401 induces a ...... is and cancer stem-like cells.
@en
A novel agent SL-401 induces a ...... is and cancer stem-like cells.
@nl
P2093
P2860
P356
P1433
P1476
A novel agent SL-401 induces a ...... is and cancer stem-like cells.
@en
P2093
C L Brooks
K C Anderson
P Richardson
P2860
P2888
P304
P356
10.1038/LEU.2017.135
P577
2017-05-08T00:00:00Z